University of Virginia School of Medicine scientists have uncovered a key reason why HIV remains so difficult to cure: Their research shows that small changes in the virus affect how quickly or slowly ...

People with HIV may have to take multiple medicines just to keep the virus under control. Medicines for HIV are usually taken every day, and it is crucial that people do not miss their dose or else ...

How Does Yeztugo Work to Prevent HIV? HIV is a virus that has a coating around it, which is called a capsid. In order for HIV to make copies of itself and spread within your body, it needs to get ...

Cabotegravir was already approved for use in England and Wales as part of a combination treatment for people living with HIV.

University of Virginia School of Medicine scientists have uncovered a key reason why HIV remains so difficult to cure: Their research shows that small changes in the virus affect how quickly or slowly ...

On October 20, 2025, scientists announced a significant advancement toward curing HIV, marking a pivotal moment in the ...

University of Virginia School of Medicine scientists have uncovered a key reason why HIV remains so difficult to cure, bringing researchers closer to finding ways to flush out the dormant virus and ...

A federal grant for HIV research is part of $15.7 million the National Institutes for Health awarded to the Wertheim UF ...

A woman who received a stem cell transplant to treat her HIV is still virus-free more than five years after the procedure and 30 months after she stopped taking HIV medication. When you purchase ...

Lenacapavir works to both treat and prevent HIV, making it a promising drug should it be approved by the FDA later this month. It works both ways. Lenacapavir is in a brand new class of drugs called a ...

British pharma giant GSK on Wednesday announced promising results for a long-acting injectable HIV therapy, offering a hopeful alternative for people who take daily pills to halt the virus’s ...